Aberrant Promoter Hypomethylation of Sortilin 1: A Moyamoya Disease Biomarker

Aberrant Promoter Hypomethylation of Sortilin 1: A Moyamoya Disease Biomarker

Background and Purpose The pathogenesis of moyamoya disease (MMD) remains poorly understood, and no reliable molecular biomarkers for MMD have been identified to date. The present study aimed to identify epigenetic biomarkers for use in the diagnosis of MMD. Methods We performed integrated analyses...

Full description

Bibliographic Details
Main Authors: Hye Youn Sung, Ji Yeoun Lee, Ae Kyung Park, Youn Joo Moon, Inho Jo, Eun-Mi Park, Kyu-Chang Wang, Ji Hoon Phi, Jung-Hyuck Ahn, Seung-Ki Kim
Format: Article
Language:English
Published: Korean Stroke Society 2018-09-01
Series:Journal of Stroke
Subjects:
moyamoya disease
dna methylation
biomarkers
diagnosis
sortilin 1
Online Access:http://www.j-stroke.org/upload/pdf/jos-2018-00962.pdf

Internet

http://www.j-stroke.org/upload/pdf/jos-2018-00962.pdf

Similar Items